Blood · 2016
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES.
Show affiliations
- Swerdlow SH — Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA;
- Campo E — Department of Pathology, Hospital Clinic, University of Barcelona, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain;
- Pileri SA — Haematopathology Unit, European Institute of Oncology, Milan, and Department of Experimental, Diagnostic and Specialty Medicine, Bologna University Medical School, Bologna, Italy;
- Harris NL — Department of Pathology, Harvard Medical School and Massachusetts General Hospital, Boston, MA;
- Stein H — Pathodiagnostik, Berlin, Germany;
- Siebert R — Institute of Human Genetics, Christian Albrechts University Kiel, Kiel, Germany;
- Advani R — Division of Oncology, Department of Medicine, Stanford University, Stanford, CA;
- Ghielmini M — Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
- Salles GA — Department of Hematology, Hospices Civils de Lyon, and Université Claude Bernard Lyon-1, Lyon, France;
- Zelenetz AD — Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; and.
- Jaffe ES — Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
6 read1 want to readRigor 3.8Novelty 3.2Impact 3.2Reprod. 3.2
Most-cited papers citing this
- Cell Genom · 2026 · cited by 2
- J Clin Oncol · 2026 · cited by 2
- Blood Adv · 2026 · cited by 1
- Sci Adv · 2026 · cited by 1
- Hematology Am Soc Hematol Educ Program · 2025 · cited by 1
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0